What is the pathophysiology of anemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pathophysiology of Anemia

Anemia is fundamentally caused by three major pathophysiologic mechanisms: decreased production of functional red blood cells, increased destruction of red blood cells, or blood loss, all leading to reduced oxygen-carrying capacity of the blood. 1

Definition and Classification

  • Anemia is defined as a reduction in hemoglobin concentration, red blood cell count, or packed cell volume below normal levels (typically <13.5 g/dL in men and <12.0 g/dL in women) 2
  • Severity is classified as mild (Hb 10-11.9 g/dL), moderate (Hb 8.0-9.9 g/dL), or severe (Hb <8.0 g/dL) 3

Major Pathophysiologic Mechanisms

1. Decreased Production of Red Blood Cells

  • Erythropoietin Deficiency: Specialized interstitial cells in the kidney cortex sense tissue hypoxia and produce erythropoietin in response; kidney disease impairs this production 3
  • Iron Deficiency: Iron is essential for hemoglobin synthesis; deficiency leads to microcytic anemia and is the most common nutritional cause of anemia worldwide 1
  • Vitamin Deficiencies: B12 and folate deficiencies impair DNA synthesis in rapidly dividing erythroblasts, leading to ineffective erythropoiesis and macrocytic anemia 3, 1
  • Bone Marrow Disorders: Direct infiltration by cancer cells, myelodysplastic syndromes, or radiation/chemotherapy-induced myelosuppression can reduce red blood cell production 1, 2
  • Inflammation-Mediated: Inflammatory cytokines (TNF-α, IL-6) cause:
    • Inadequate erythropoietin production despite anemia
    • Suppressed erythropoietic response of red cell precursors
    • Increased hepcidin synthesis, leading to iron sequestration and reduced iron availability for erythropoiesis 3

2. Increased Destruction of Red Blood Cells

  • Hemolysis: Premature destruction of red blood cells can be:
    • Immune-mediated (autoimmune hemolytic anemia)
    • Drug-induced
    • Due to mechanical factors (damaged heart valves)
    • Result of intrinsic red cell defects (hemoglobinopathies, enzyme deficiencies) 2
  • Methemoglobinemia: Oxidation of ferro-iron (Fe²⁺) to ferri-iron (Fe³⁺) in hemoglobin creates methemoglobin, which cannot transport oxygen effectively, resulting in "functional anemia" 3

3. Blood Loss

  • Acute Hemorrhage: Rapid blood loss from trauma or internal bleeding 1
  • Chronic Blood Loss: Slow, persistent bleeding from gastrointestinal tract, heavy menstrual bleeding, or tumor sites 3, 1

Complex Pathophysiology in Specific Conditions

Anemia in Chronic Heart Failure

  • Multifactorial etiology with prevalence ranging from 6-70% of heart failure patients 3
  • Contributing factors include:
    • Iron deficiency (50-70% of cases)
    • Hemodilution due to expanded plasma volume
    • Inflammatory cytokine production (TNF-α, IL-6)
    • Renal dysfunction with reduced erythropoietin production
    • Medication effects (ACE inhibitors, anticoagulants)
    • Hepcidin-mediated iron sequestration 3
  • Associated with worse outcomes: increased all-cause mortality (RR 1.47), hospitalization (RR 1.28), and heart failure hospitalization (RR 1.43) 3

Anemia in Chronic Kidney Disease

  • Nearly universal in advanced CKD (stage 5) 1
  • Primarily caused by decreased erythropoietin production from damaged kidney cells 3
  • Additional factors include:
    • Iron deficiency (absolute or functional)
    • Shortened red cell survival
    • Uremic toxins suppressing erythropoiesis
    • Chronic inflammation 3, 1

Anemia in Cancer

  • Multiple simultaneous mechanisms often contribute:
    • Direct bone marrow infiltration by malignant cells
    • Cytokine-mediated inflammation
    • Chemotherapy or radiation-induced myelosuppression
    • Nutritional deficiencies
    • Chronic blood loss from tumor sites 3, 1

Physiologic Consequences of Anemia

  • Decreased oxygen-carrying capacity leads to tissue hypoxia 4
  • Compensatory mechanisms include:
    • Increased cardiac output
    • Redistribution of blood flow to vital organs
    • Increased oxygen extraction
    • Rightward shift of the oxygen-hemoglobin dissociation curve 4
  • When anemia develops gradually, these compensatory mechanisms allow adaptation to lower hemoglobin levels 4, 5
  • In acute anemia or in patients with limited cardiopulmonary reserve, these mechanisms may be insufficient, leading to symptoms 4

Diagnostic Approach

  • Complete blood count with reticulocyte count to assess bone marrow response 1, 2
  • Peripheral blood smear examination for morphological clues 2
  • Iron studies (serum iron, ferritin, total iron binding capacity, transferrin saturation) 1, 2
  • Kidney function tests (GFR, creatinine) when renal cause is suspected 1
  • Vitamin B12 and folate levels 1, 2
  • Special tests as indicated (Coombs test for hemolysis, bone marrow examination) 3, 2

Clinical Implications

  • Multiple mechanisms often contribute simultaneously to anemia, especially in complex medical conditions 1
  • Ferritin may be falsely elevated despite true iron deficiency in chronic inflammatory states 1
  • Normal hemoglobin values vary by sex, race, smoking status, and altitude 1
  • The combination of anemia, chronic kidney disease, and heart failure (cardio-renal anemia syndrome) has particularly poor outcomes 3

Understanding the pathophysiologic mechanisms of anemia is essential for appropriate diagnosis and treatment, as addressing the underlying cause is the cornerstone of management.

References

Guideline

Causes of Very Low Hemoglobin and Hematocrit Levels

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Anemia Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pathophysiology of anemia.

The American journal of medicine, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.